Cart
sales@molnova.com
4-CMTB
CAS No. 300851-67-6
4-CMTB( —— )
Catalog No. M22376 CAS No. 300851-67-6
4-CMTB is a selective agonist of FFA2 and GPR43.It also is a positive allosteric modulator (pEC50=6.38).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 88 | In Stock |
|
| 2MG | 56 | In Stock |
|
| 5MG | 84 | In Stock |
|
| 10MG | 133 | In Stock |
|
| 25MG | 231 | In Stock |
|
| 50MG | 334 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-CMTB
-
NoteResearch use only, not for human use.
-
Brief Description4-CMTB is a selective agonist of FFA2 and GPR43.It also is a positive allosteric modulator (pEC50=6.38).
-
Description4-CMTB is a selective agonist of FFA2 and GPR43.It also is a positive allosteric modulator (pEC50=6.38).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorfree fatty acid receptor 2 (FFA2/GPR43)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number300851-67-6
-
Formula Weight294.8
-
Molecular FormulaC14H15ClN2OS
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (339.21 mM; Need ultrasonic)
-
SMILESCC(C)C(C(=O)Nc1nccs1)c1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Milligan G, Stoddart LA, Smith NJ. Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3. Br J Pharmacol. 2009;158(1):146-153.
molnova catalog
related products
-
PF-1355
PF-1355 is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.
-
Avoralstat
Avoralstat is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.
-
Activated Protein C ...
The peptide region containing residues 390-404 in Activated Protein C (APC) is essential for anticoagulant activity and is available for interaction with antibodies or with other proteins, such as the macromolecular substrates Factors Va or VIIIa. APC regulates blood coagulation by proteolytic inactivation of the blood coagulation cofactors Va and VIIIa.
